Stockreport

bluebird bio Reports Third Quarter 2024 Results and Highlights Operational Progress and 2024 Guidance

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF - 74 patient starts completed or scheduled to date in 2024 across bluebird’s commercial portfolio -- Third quarter 2024 net revenue of $10.6 million reflects quarter-to- [Read more]